Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Hemodialysis I: Introduction01:25

Hemodialysis I: Introduction

4.0K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
4.0K
Dialysis01:27

Dialysis

2.2K
Renal failure occurs when the kidneys lose their ability to filter waste products from the blood effectively. It can be classified into two types: acute renal failure (ARF) and chronic renal failure (CRF).
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
2.2K
Dialysis01:15

Dialysis

2.1K
Dialysis is a diffusion-based purification process that separates analyte molecules from a complex matrix. This is accomplished by allowing molecules in the solution to pass through a semipermeable membrane into a liquid on the other side. The membrane is usually made of cellulose acetate or cellulose nitrate, and the second liquid must be miscible with the solution. Ions (e.g., chloride or sodium) or organic molecules (e.g., glucose) can pass through the membrane pores, which generally have...
2.1K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

2.2K
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
2.2K
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis01:30

Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis

1.1K
Patients with end-stage renal disease (ESRD) or those experiencing drug overdose often require extracorporeal methods to eliminate accumulated drugs and metabolites. Hemoperfusion, hemofiltration, and dialysis are the primary techniques to rapidly remove harmful substances without disrupting the patient's fluid and electrolyte balance. For those with compromised renal function, dosage adjustments of concurrent medications may be necessary during extracorporeal drug removal.Dialysis is a process...
1.1K
Hemodialysis III: Nursing Management01:25

Hemodialysis III: Nursing Management

1.8K
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Solid pseudopapillary epithelial neoplasm of the pancreas: an audit of 29 cases operated in a tertiary Indian centre.

Annals of gastroenterology·2026
Same author

Duodenal fistula secondary to erosion by an expanded polytetrafluoroethylene graft in a living donor liver transplant: a case report and review of the literature.

Frontiers in transplantation·2026
Same author

Reliability of the Beit CURE classification for the management of chronic hematogenous osteomyelitis of the long bones in children.

Journal of pediatric orthopedics. Part B·2026
Same author

Sequential correction of clubfoot deformities with Ponseti casting and tenotomy: Insights from the Dimeglio scoring framework.

Foot (Edinburgh, Scotland)·2026
Same author

Talar Index: A New Radiologic Marker for Clubfoot Equinus.

Journal of pediatric orthopedics·2026
Same author

Concomitant prophylactic trochanteric epiphysiodesis may not be an effective procedure for Perthes varus surgery.

Journal of clinical orthopaedics and trauma·2026

Related Experiment Video

Updated: May 3, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K

Dialysis therapies: a National Dialogue.

Rajnish Mehrotra1, Anil Agarwal, Joanne M Bargman

  • 1Kidney Research Institute, Division of Nephrology, Department of Medicine, University of Washington, Seattle, Washington;, †Ohio State University, Columbus, Ohio;, ‡University Health Network, Toronto, Ontario, Canada;, §University of California, San Francisco, California;, ‖Oregon Health and Science University, Portland, Oregon;, ¶Emory University, Atlanta, Georgia, *National Institute of Diabetes, Digestive, and Kidney Disease, National Institutes of Health, Bethesda, Maryland.

Clinical Journal of the American Society of Nephrology : CJASN
|January 25, 2014
PubMed
Summary

Researchers prioritized kidney research to improve outcomes for end-stage renal disease (ESRD) patients by reducing mortality and enhancing quality of life. Key areas include identifying toxins, advancing dialysis technology, and improving vascular access.

More Related Videos

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.0K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

1.8K

Related Experiment Videos

Last Updated: May 3, 2026

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice
06:27

A Retrograde Implantation Approach for Peritoneal Dialysis Catheter Placement in Mice

Published on: July 20, 2022

2.9K
Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
07:11

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis

Published on: July 19, 2018

15.0K
A Murine Model of Hemodialysis Access-Related Hand Dysfunction
08:39

A Murine Model of Hemodialysis Access-Related Hand Dysfunction

Published on: May 31, 2022

1.8K

Area of Science:

  • Nephrology
  • Renal Disease Research
  • Public Health

Background:

  • The National Institute of Diabetes, Digestive, and Kidney Diseases convened the Kidney Research National Dialogue.
  • Participants identified critical needs in kidney research to improve patient outcomes.

Purpose of the Study:

  • To formulate and prioritize research objectives for advancing understanding of kidney function and disease.
  • To outline strategies for improving outcomes in end-stage renal disease (ESRD).

Main Methods:

  • Convening scientific community participants for a national dialogue.
  • Prioritizing research areas based on expert consensus.

Main Results:

  • Improving ESRD outcomes by decreasing mortality and morbidity is a high priority.
  • Enhancing quality of life for ESRD patients is a key research goal.

Conclusions:

  • Research must focus on identifying retained toxins in kidney disease.
  • Technological advances in dialysate and devices are needed for toxin removal.
  • Improving vascular access and reducing disease burden in dialysis patients are crucial.